Zealand Pharma

Director

• Lead the design, execution, and communication of health, economic and outcomes research strategies supporting the company’s global metabolic health portfolio.
• Generate high-quality real-world, clinical, and economic evidence to demonstrate product value to payers, providers, patients, and policymakers.
• Develop and implement integrated global HEOR strategies to support pipeline and lifecycle management programs with a US launch focus.
• Lead development of US RWD strategies and partnerships with academic consortia, claims databases, and health systems to support value demonstration effective effectiveness and longitudinal outcomes studies.
• Design and implement real-world data analyses to understand and articulate the current patient demographics, treatment patterns, and outcomes.
• Develop AMCP value dossiers, economic modelling and narratives and scientific publications to support value propositions.
• Serve as a key domain expert for payer engagement, providing evidence summaries and presentations that strengthen product positioning and formulary access.
• Engage and collaborate with external partners including payers, providers, and other access decision-makers to establish / maintain strong partnerships and gather insights.
• Lead the external dissemination of HEOR/RWE deliverables including publications, presentations, and professional conferences.
• Provide input to clinical development programs.

Director, HEOR & RWE